Evaluation of the QuantiFERON SARS-CoV-2 assay to assess cellular immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in individuals with low and high humoral response

Vaccines against SARS-CoV-2 are known to be less immunogenic for some individuals, whereas others present notably high levels of antibody production. We assessed the cellular response to BNT162b2 among individuals with low post-vaccination antibody levels as well as in a small group of individuals w...

Descripción completa

Detalles Bibliográficos
Autores principales: Tychala, Areti, Meletis, Georgios, Katsimpourlia, Eugenia, Gkeka, Ioanna, Dimitriadou, Rodoula, Sidiropoulou, Eleni, Skoura, Lemonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567290/
https://www.ncbi.nlm.nih.gov/pubmed/34714711
http://dx.doi.org/10.1080/21645515.2021.1991710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567290/
https://www.ncbi.nlm.nih.gov/pubmed/34714711
http://dx.doi.org/10.1080/21645515.2021.1991710

Ejemplares similares